121 related articles for article (PubMed ID: 10779660)
1. Intrathecally administered spermine produces the scratching, biting and licking behaviour in mice.
Tan-No K; Taira A; Wako K; Niijima F; Nakagawasai O; Tadano T; Sakurada C; Sakurada T; Kisara K
Pain; 2000 May; 86(1-2):55-61. PubMed ID: 10779660
[TBL] [Abstract][Full Text] [Related]
2. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
[TBL] [Abstract][Full Text] [Related]
4. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
[TBL] [Abstract][Full Text] [Related]
5. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Furuta S; Sato T; Satoh S; Yasuhara H; Tadano T
J Pharmacol Sci; 2007 May; 104(1):39-45. PubMed ID: 17452810
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.
Sakurada T; Katsuyama S; Sakurada S; Inoue M; Tan-No K; Kisara K; Sakurada C; Ueda H; Sasaki J
Br J Pharmacol; 1999 Aug; 127(7):1712-8. PubMed ID: 10455330
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
[TBL] [Abstract][Full Text] [Related]
8. Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation.
Tan-No K; Takahashi H; Nakagawasai O; Niijima F; Sato T; Satoh S; Sakurada S; Marinova Z; Yakovleva T; Bakalkin G; Terenius L; Tadano T
Pain; 2005 Feb; 113(3):301-309. PubMed ID: 15661437
[TBL] [Abstract][Full Text] [Related]
9. Spinal ERK activation via NO-cGMP pathway contributes to nociceptive behavior induced by morphine-3-glucuronide.
Komatsu T; Sakurada S; Kohno K; Shiohira H; Katsuyama S; Sakurada C; Tsuzuki M; Sakurada T
Biochem Pharmacol; 2009 Oct; 78(8):1026-34. PubMed ID: 19589334
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of tachykinin NK(1) and NMDA receptors in histamine-induced hyperalgesia in mice.
Sakurada S; Orito T; Sakurada C; Sato T; Hayashi T; Mobarakeh JI; Yanai K; Onodera K; Watanabe T; Sakurada T
Eur J Pharmacol; 2002 Jan; 434(1-2):29-34. PubMed ID: 11755162
[TBL] [Abstract][Full Text] [Related]
11. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse.
Velázquez RA; Kitto KF; Larson AA
J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858
[TBL] [Abstract][Full Text] [Related]
12. Effects of intrathecally injected glutamate and substance P antagonists on repeated cold stress-induced hyperalgesia in rats.
Okano K; Kuraishi Y; Satoh M
Biol Pharm Bull; 1995 Jan; 18(1):42-4. PubMed ID: 7537576
[TBL] [Abstract][Full Text] [Related]
13. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
14. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
[TBL] [Abstract][Full Text] [Related]
15. Involvement of glial cells in the nociceptive behaviors induced by a high-dose of histamine administered intrathecally.
Mizoguchi H; Komatsu T; Iwata Y; Watanabe C; Watanabe H; Orito T; Katsuyama S; Yonezawa A; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2011 Feb; 653(1-3):21-5. PubMed ID: 21118680
[TBL] [Abstract][Full Text] [Related]
16. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
Carter CJ; Lloyd KG; Zivkovic B; Scatton B
J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evidence for involvement of excitatory amino acids in aversive responses induced by intrathecal substance P in rats.
Okano K; Kuraishi Y; Satoh M
Biol Pharm Bull; 1993 Sep; 16(9):861-5. PubMed ID: 7505686
[TBL] [Abstract][Full Text] [Related]
18. Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: possible involvement of substance P in the mouse spinal cord.
Sakurada T; Wako K; Sakurada C; Manome Y; Tan-no K; Sakurada S; Kisara K
Brain Res; 1996 Jun; 724(2):213-21. PubMed ID: 8828571
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.
Sakurada T; Yogo H; Manome Y; Tan-No K; Sakurada S; Yamada A; Kisara K; Ohba M
Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):387-92. PubMed ID: 7531295
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
